Related Experiment Video
Updated: May 26, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Synaptic protein alterations in Parkinson's disease.
Ilse S Pienaar1, David Burn, Christopher Morris
1Institute for Ageing and Health, Department of Neurology, The University of Newcastle, Newcastle-Upon-Tyne, UK. ilse-sanet.pienaar@ncl.ac.uk
Parkinson's disease (PD) damages neuronal axons and synapses. New therapies targeting protein synthesis and degradation at these sites are needed to preserve neural network function.
Area of Science:
- Neuroscience
- Cell Biology
Background:
- Neurodegenerative diseases like Parkinson's disease (PD) affect distal neuronal compartments, including axons and synapses.
- Studies show dendritic spine loss and impaired axonal transport in PD-affected brains, highlighting synaptic and axonal vulnerability.
Purpose of the Study:
- To review current understanding of proteins involved in structural and functional synaptic changes in Parkinson's disease.
- To emphasize the need for therapeutic strategies targeting non-somatic neurodegeneration mechanisms.
Main Methods:
- Literature review of studies on protein regulation, quality control, and synaptic alterations in PD.
- Analysis of research linking protein synthesis, folding, degradation, and quality control systems to synaptic dysfunction in PD.
Main Results:
- Deregulated protein synthesis, folding, and degradation are linked to synaptic morphological and functional alterations in PD.
- Inadequate understanding of mechanisms regulating non-somatic neurodegeneration limits therapeutic development.
Conclusions:
- Developing therapeutics targeting protein synthesis and degradation pathways at axonal and dendritic synapses is crucial for preserving neural circuitry and function in PD.
- Further research into independent mechanisms of non-somatic neurodegeneration is necessary.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Neural Regulation
Alterations in Muscle Tone lll
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

